Clinical Trial Update: NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating NBTXR3 in combination with chemotherapy and radiation therapy for esophageal cancer; recruitment is ongoing across multiple stages and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• NBTXR3 (hafnium oxide nanoparticles)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Phase 1 | Status: RECRUITING